Trial intelligence / Profile preview

Kaletra Monotherapy vs Trizivir for Lipoatrophy Prevention in HIV

NCT00865475Phase 4Completed

Sponsor
Fundación SEIMC-GeSIDA
Start
Dec 2008
Primary completion
Mar 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Fundación SEIMC-GeSIDA. Started Dec 2008; status: completed.

02

Drugs

lopinavir + ritonavir
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT00865475.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00865475.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call